Insider Transactions

Insider Transactions

Date Name Title Type Filing Shares Traded Price Range Total Held
Jan 04, 2021 Chief Science Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) Form 4 34,572 -- 415,618
Jan 04, 2021 Chief Science Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) Form 4 55,675 -- 55,675
Jan 03, 2021 Chief Science Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Form 4 8,938 $23.09 381,046
Jan 02, 2021 Chief Science Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Form 4 14,358 $23.09 389,984
Dec 31, 2020 Chief Science Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Form 4 5,340 $23.09 404,342
Dec 14, 2020 Chief Science Officer Open market or private sale of non-derivative or derivative security Form 4 111,125 $23.88 409,682
Oct 09, 2020 Chief Science Officer Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Form 4 43,700 $8.61 564,507
Oct 09, 2020 Chief Science Officer Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Form 4 75,000 $12.28 639,507
Oct 09, 2020 Chief Science Officer Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Form 4 75,000 $9.03 714,507
Oct 09, 2020 Chief Science Officer Open market or private sale of non-derivative or derivative security Form 4 193,700 $15.03 520,807

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.